FIELD: veterinary medicine.
SUBSTANCE: method comprises application of the vaccine into the cell culture of kidney of saiga, incubation for 1 hour at a temperature of 37±0.5°C, washing of the cell monolayer with the medium Igla MEM without serum, application of maintenance medium Igla with 2% cattle serum, incubation of the culture at a temperature of 37±0.5°C for 3-4 days, freezing of the culture at a temperature of -40°C, thawing, carrying out the 2nd passage in the above-mentioned manner, titrating of the obtained material and carrying out evaluation by the method of direct immunofluorescence on the 9-11th day.
EFFECT: invention may be used in research institutes and biofactories under the control of inactivated antirabic vaccine, namely in assessing its completeness of inactivation.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING ANTIRABIC INACTIVATED CULTURAL VACCINE | 1994 |
|
RU2077338C1 |
ANTIRABIC INACTIVATED EMULSION CULTURE VACCINE FOR PROPHYLACTIC IMMUNIZATION OF DOMESTIC CARNIVORES AND FARM ANIMALS | 2019 |
|
RU2722868C1 |
METHOD FOR TITRATION OF ANTIRABIC VIRUS-NEUTRALIZING ANTIBODIES | 2003 |
|
RU2254575C2 |
METHOD FOR DETERMINING SPECIFIC ACTIVITY OF ANTI-RABIES IMMUNOGLOBULIN ON CELL CULTURE USING ATOMIC FORCE MICROSCOPY | 2018 |
|
RU2688334C1 |
METHOD OF INDIRECT DETERMINATION OF THE COMPLETENESS OF RABIES VIRUS ANTIGEN INACTIVATION USING REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION FOLLOWED BY ELECTROPHORESIS OF AMPLICONS IN AGAROSE GEL | 2020 |
|
RU2746588C1 |
METHOD OF ASSAY OF ANTIRABIES VIRUS-NEUTRALIZING ANTIBODIES | 1997 |
|
RU2130187C1 |
SERUM-FREE ENVIRONMENT “VNIIZZH” FOR THE CULTIVATION OF VNK-21 KIDNEY CELLS OF THE SYRIAN HAMSTER AND THE PRODUCTION OF IMMUNOGENIC COMPONENTS OF CULTURE-BASED VIRUSES OF FOOT-AND-MOUTH DISEASE AND RABIES FOR THE MANUFACTURE OF VACCINES | 2021 |
|
RU2770814C1 |
ATTENUATED STRAIN OF NAIROBI SHEEP DISEASE VIRUS | 2007 |
|
RU2348692C1 |
METHOD FOR MANUFACTURING RABIES INACTIVATED VACCINE FOR FARM ANIMALS | 2003 |
|
RU2244557C2 |
STRAIN RABIES VIRUS N777-M USED FOR CONTROLLING IMMUNOGENIC ACTIVITY OF ANTIRABIC VACCINES | 0 |
|
SU908795A1 |
Authors
Dates
2013-09-10—Published
2012-02-29—Filed